Industry Update: Clinical Research Organizations
VRC is proud to release its latest industry report. The report provides a concise, insightful update on the Clinical Research Organizations industry including recent transactions, market multiples, company performance and purchase price allocation percentages.
- On July 2, 2021, ICON completed the previously announced acquisition of contract research company PRA Health Sciences for a total consideration of approximately $12.0 billion. The companies signed a merger agreement in February 2021, under which ICON paid $80.0 in cash per share and 0.4125 shares of its stock to PRA shareholders.
- On June 25, 2021, PerkinElmer completed the purchase of Nexcelom Bioscience from Ampersand Capital Partners for $260 million in cash. Nexcelom is the manufacturer of Cellometer, Cellaca MX, and Celigo image cytometry products for cell analysis in drug discovery, development, and manufacturing workflows.
Past Industry Updates
More Industry Reports